Achilles Therapeutics PLC (ADR - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACHL Nasdaq 8731 https://www.achillestx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achilles Therapeutics PLC (ADR

Is Anika Therapeutics (ANIK) Stock Outpacing Its Medical Peers This Year? - Jan 17th, 2023 2:40 pm
Achilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Dec 20th, 2022 1:30 pm
Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022 - Dec 6th, 2022 11:00 am
Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022 - Nov 30th, 2022 11:05 pm
Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method - Nov 22nd, 2022 1:00 pm
Is Achilles Therapeutics (NASDAQ:ACHL) In A Good Position To Deliver On Growth Plans? - Nov 13th, 2022 12:48 pm
Achilles Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights - Nov 8th, 2022 12:00 pm
What Makes Achilles Therapeutics PLC Sponsored ADR (ACHL) a New Buy Stock - Nov 1st, 2022 4:00 pm
Achilles Therapeutics Co-founder Professor Charles Swanton to Participate in Expert Roundtable Highlighting Pivotal Nature of Neoantigens as Targets in Cancer Cell Therapy - Oct 6th, 2022 12:30 pm
Gilead's (GILD) Tecartus Gets EC Nod for New Cancer Indication - Sep 7th, 2022 5:15 pm
Curis (CRIS) Gets FDA Nod to Partly Resume Leukemia Study - Aug 31st, 2022 4:53 pm
Kodiak Sciences (KOD) Rises 60% in Past 3 Months: Here's Why - Aug 26th, 2022 5:34 pm
AstraZeneca (AZN) Gets Japan Nod for Expanded Use of 3 Drugs - Aug 25th, 2022 3:53 pm
Amgen (AMGN) Posts Positive Data from Soliris' Biosimilar Study - Aug 24th, 2022 5:33 pm
Horizon (HZNP) Marketed Drugs Aid Growth, Stiff Rivalry a Woe - Aug 23rd, 2022 5:53 pm
Kodiak Sciences (KOD) Focuses on Developing Eye Drug Tarcocimab - Aug 19th, 2022 4:32 pm
Horizon (HZNP) Inks Collaboration Deal with Q32 Bio for ADX-914 - Aug 16th, 2022 2:09 pm
Achilles Therapeutics Reports Second Quarter 2022 Financial Results and Recent Business Highlights - Aug 9th, 2022 11:00 am
What Is The Ownership Structure Like For Achilles Therapeutics plc (NASDAQ:ACHL)? - Aug 1st, 2022 10:00 am
Achilles Therapeutics to lead Horizon Europe-Funded Consortium to Advance Personalized Cell Therapy Manufacturing - Jul 21st, 2022 12:00 pm